Jay Cui

Principal

2021

Board Observer

2021 - 2021

Board Observer

2021 - 2021

Director, AbbVie Ventures

2017 - 2021

AbbVie Ventures is the venture capital arm of AbbVie and is dedicated to making equity investments in emerging biotech companies in oncology, immunology, and neurodegenerative diseases.

Board Observer

2019 - 2020

Business Consultant

2015 - 2017

Management consultant focusing on biopharma, medical device, and healthcare service industries

Management Consultant

2015 - 2015

Management consultant in the corporate development practice; advised clients in the biotechnology, medical device and animal health industries on multiple commercial and corporate strategy projects.

Library Development Core Leader

2010 - 2014

• Planned and oversaw setup of a $2M research laboratory funded by a National Institutes of Health P50 grant; Built multifunctional research team and established standard operating protocols • Led team creating 5,000+ structurally diverse, high purity chemicals for screening; established 20+ collaborative projects nationwide and with NIH MLPCN network, leading to drug leads against breast cancer, diabetes and neurodegenerative diseases • Guest lecturer for UChicago Ph.D. level course: High-Thoughtput Methods in Organic Chemistry

Corporate Portfolio Management

2014 - 2014

Internship at the Global Portfolio Management Team within the Chief Medical and Scientific Office (CMSO)